Corcept Therapeutics Clinical

Menlo Park, CA, USA Specialty Founded 1998 501-1000 employees

US-based clinical-stage CRO arm specialising in endocrinology and cortisol-modulation therapeutics with expertise in Phase I-III metabolic and CNS clinical trials.

Services

CLINICAL

Phase I Clinical Trials Phase II Clinical Trials Phase III Clinical Trials Clinical Data Management Biostatistics

REGULATORY

IND Filing Support Regulatory Strategy

Therapeutic Areas

Endocrinology Metabolic Disease CNS Oncology

Contact

Locations

Menlo Park, CA, USA

Certifications

GCP Compliant FDA Registered

Regulatory Experience

FDAEMA